Evidence map›Paper›PMID 36173071›Full record

ReviewCurrent neuropharmacology2024

Potential Therapeutic Effects of Short-Chain Fatty Acids on Chronic Pain.

Yuanyuan Tang, Juan Du, Hongfeng Wu, Mengyao Wang, Sufang Liu, Feng Tao

Open access · greenAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Gut microbiota-mediated pain sensitization: mechanisms and therapeutic implications.Frontiers in pain research (Lausanne, Switzerland) · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuanyuan TangSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China.
Juan DuSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China.
Hongfeng WuSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China.
Mengyao WangSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China.
Sufang LiuDepartment of Biomedical Sciences, College of Dentistry, Texas A&M University Dallas, Texas, USA.
Feng TaoDepartment of Biomedical Sciences, College of Dentistry, Texas A&M University Dallas, Texas, USA.
Xinxiang Medical University · CN

Funding

Doctoral Scientific Research Foundation of Xinxiang Medical University YBSKYZZ202004Key Science and Technology Program of Henan Province 212102310651
6 · The paper itself

Abstract

The intestinal homeostasis maintained by the gut microbiome and relevant metabolites is essential for health, and its disturbance leads to various intestinal or extraintestinal diseases. Recent studies suggest that gut microbiome-derived metabolites short-chain fatty acids (SCFAs) are involved in different neurological disorders (such as chronic pain). SCFAs are produced by bacterial fermentation of dietary fibers in the gut and contribute to multiple host processes, including gastrointestinal regulation, cardiovascular modulation, and neuroendocrine-immune homeostasis. Although SCFAs have been implicated in the modulation of chronic pain, the detailed mechanisms that underlie such roles of SCFAs remain to be further investigated. In this review, we summarize currently available research data regarding SCFAs as a potential therapeutic target for chronic pain treatment and discuss several possible mechanisms by which SCFAs modulate chronic pain.

Indexed as

Chronic PainGastrointestinal MicrobiomeFatty Acids, VolatileGastrointestinal TractHumansFatty Acids, Volatilechronic paingut-brain communicationgut microbiomeintestinal diseases.metabolitesShort-chain fatty acids

Identifiers

PMID36173071
PMCPMC10788890
OpenAlexW4297965182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.